Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D01TJW
|
|||
Drug Name |
PMID27109571-Compound-30
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC
|
|||
Structure |
Download2D MOL |
|||
Formula |
C19H18Cl2N2O3
|
|||
Canonical SMILES |
C1CCC(C1)(C(=O)O)NC(=O)NC2=C(C(=CC(=C2)Cl)Cl)C3=CC=CC=C3
|
|||
InChI |
1S/C19H18Cl2N2O3/c20-13-10-14(21)16(12-6-2-1-3-7-12)15(11-13)22-18(26)23-19(17(24)25)8-4-5-9-19/h1-3,6-7,10-11H,4-5,8-9H2,(H,24,25)(H2,22,23,26)
|
|||
InChIKey |
XKZSVPIUPDFCIQ-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Fatty acid-binding protein 4 (FABP4) | Target Info | Inhibitor | [1] |
Fatty acid-binding protein 5 (FABP5) | Target Info | Inhibitor | [1] | |
Target's Patent Info | Fatty acid-binding protein 4 (FABP4) | Target's Patent Info | [1] | |
Fatty acid-binding protein 5 (FABP5) | Target's Patent Info | [1] | ||
KEGG Pathway | PPAR signaling pathway | |||
NetPath Pathway | IL1 Signaling Pathway | |||
TCR Signaling Pathway | ||||
Pathway Interaction Database | AP-1 transcription factor network | |||
Reactome | Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis | |||
Transcriptional regulation of white adipocyte differentiation | ||||
WikiPathways | Lipid digestion, mobilization, and transport | |||
Transcriptional Regulation of White Adipocyte Differentiation |
References | Top | |||
---|---|---|---|---|
REF 1 | Fatty acid binding protein (FABP) inhibitors: a patent review (2012-2015).Expert Opin Ther Pat. 2016 Jul;26(7):767-76. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.